Brigitte Pan‐Petesch

1.5k total citations
48 papers, 598 citations indexed

About

Brigitte Pan‐Petesch is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Brigitte Pan‐Petesch has authored 48 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 19 papers in Genetics and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Brigitte Pan‐Petesch's work include Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (15 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Brigitte Pan‐Petesch is often cited by papers focused on Platelet Disorders and Treatments (20 papers), Hemophilia Treatment and Research (15 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Brigitte Pan‐Petesch collaborates with scholars based in France, United States and Austria. Brigitte Pan‐Petesch's co-authors include Jean‐François Abgrall, Jérôme Duchemin, Toshko Lissitchkov, Elena Santagostino, Karine Lacut, Ingrid Pabinger, Johannes Oldenburg, Paul Guéguen, Carmen Altisent and U. Martinowitz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Brigitte Pan‐Petesch

36 papers receiving 585 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Brigitte Pan‐Petesch 457 154 69 67 66 48 598
Huub P J Willems 267 0.6× 154 1.0× 68 1.0× 49 0.7× 85 1.3× 7 529
Angie Tuttle 607 1.3× 103 0.7× 63 0.9× 109 1.6× 38 0.6× 18 729
M. Bhavnani 335 0.7× 178 1.2× 50 0.7× 69 1.0× 100 1.5× 23 514
Tamara Everington 192 0.4× 240 1.6× 174 2.5× 88 1.3× 103 1.6× 23 502
Elsy Sjörin 547 1.2× 106 0.7× 142 2.1× 92 1.4× 87 1.3× 16 696
Piedad Villa 339 0.7× 64 0.4× 26 0.4× 119 1.8× 208 3.2× 27 494
Livia Robbiolo 292 0.6× 335 2.2× 42 0.6× 43 0.6× 22 0.3× 6 500
M.C. Trzeciak 318 0.7× 39 0.3× 63 0.9× 56 0.8× 72 1.1× 20 424
Ariela Zivelin 678 1.5× 174 1.1× 34 0.5× 143 2.1× 149 2.3× 17 790
Aurélie Rousseau 161 0.4× 26 0.2× 72 1.0× 54 0.8× 116 1.8× 34 393

Countries citing papers authored by Brigitte Pan‐Petesch

Since Specialization
Citations

This map shows the geographic impact of Brigitte Pan‐Petesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Pan‐Petesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Pan‐Petesch more than expected).

Fields of papers citing papers by Brigitte Pan‐Petesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Pan‐Petesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Pan‐Petesch. The network helps show where Brigitte Pan‐Petesch may publish in the future.

Co-authorship network of co-authors of Brigitte Pan‐Petesch

This figure shows the co-authorship network connecting the top 25 collaborators of Brigitte Pan‐Petesch. A scholar is included among the top collaborators of Brigitte Pan‐Petesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigitte Pan‐Petesch. Brigitte Pan‐Petesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moulis, Guillaume, Sylvain Audia, Louis Terriou, et al.. (2025). Efficacy and safety of dapsone in adult primary immune thrombocytopenia. Blood Advances. 9(8). 1976–1983.
2.
Guillet, Benoît, Roseline d’Oiron, Marc Trossaërt, et al.. (2025). F8 gene variants influence the response to desmopressin in hemophilia A carriers. Blood. 146(16). 1991–2004.
3.
4.
Goudemand, Jenny, Sophie Susen, Claire Berger, et al.. (2025). Health-related quality of life in children with von Willebrand disease: results of the French real-life Willebrand Study Health-related Quality of Life study. Journal of Thrombosis and Haemostasis. 23(9). 2736–2750.
5.
Pan‐Petesch, Brigitte, et al.. (2024). A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology. Research and Practice in Thrombosis and Haemostasis. 8(5). 102516–102516.
6.
Moreuil, Claire de, Brigitte Pan‐Petesch, Hubert Galinat, et al.. (2024). Predelivery Haemostatic Biomarkers in Women with Non-Severe Postpartum Haemorrhage. Journal of Clinical Medicine. 13(14). 4231–4231. 1 indexed citations
7.
Moreuil, Claire de, Yesim Dargaud, Christophe Nougier, et al.. (2023). Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery. Journal of Thrombosis and Haemostasis. 21(11). 3099–3108. 3 indexed citations
8.
Couturaud, Françis, Clément Hoffmann, Luc Bressollette, et al.. (2023). Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis. Thrombosis Research. 226. 93–99. 5 indexed citations
9.
Guillet, Benoît, B. Wibaut, Annie Harroche, et al.. (2023). A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis. Thrombosis and Haemostasis. 123(5). 490–500. 2 indexed citations
10.
Gall‐Ianotto, C. Le, et al.. (2023). Differences between aquagenic and non‐aquagenic pruritus in myeloproliferative neoplasms: An observational study of 500 patients. Journal of the European Academy of Dermatology and Venereology. 37(6). 1175–1183.
11.
Dargaud, Yesim, Antoine Rauch, Anne Lienhart, et al.. (2023). Modèle hub & spoke en France : organisation des soins et parcours des patients pour la thérapie génique de l’hémophilie. Hématologie. 29(2). 88–106. 3 indexed citations
12.
Wargny, Matthieu, Yohann Repessé, Benoît Guillet, et al.. (2022). rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings. European Journal of Clinical Investigation. 52(10). e13824–e13824.
13.
Pan‐Petesch, Brigitte, Pierre‐François Dupré, Emmanuel Nowak, et al.. (2022). Excessive gestational weight gain is an independent risk factor for gestational diabetes mellitus in singleton pregnancies: Results from a French cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 275. 31–36. 9 indexed citations
14.
Moreuil, Claire de, Brigitte Pan‐Petesch, Pierre‐François Dupré, et al.. (2022). Clinical risk factors for vasculo-placental disorders: results from a prospective case-control study nested in HEMOTHEPP French cohort study. Journal of Gynecology Obstetrics and Human Reproduction. 52(1). 102511–102511. 3 indexed citations
15.
Desprez, Dominique, Claire Flaujac, Brigitte Pan‐Petesch, et al.. (2021). Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures. Haemophilia. 27(2). 270–276. 9 indexed citations
16.
Gillet, Benjamin, Benoît Guillet, Philippe Beurrier, et al.. (2020). Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study. Haemophilia. 26(6). 1046–1055. 5 indexed citations
17.
Tromeur, Cécile, Raphaël Le Mao, P. Jégo, et al.. (2018). Facteurs de risque de maladie veineuse thromboembolique chez les jeunes femmes en contexte hormonal. Revue des Maladies Respiratoires. 36(2). 219–226.
18.
Borel‐Derlon, Annie, Jenny Goudemand, Dominique Desprez, et al.. (2018). Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol.. Blood. 132(Supplement 1). 2468–2468.
19.
Moreuil, Claire de, A.L. Fauchais, Philippe Merviel, et al.. (2018). Prévention de la pré-éclampsie en 2018 en population générale et chez la femme lupique : à l’aube d’une médecine personnalisée ?. La Revue de Médecine Interne. 39(12). 935–941. 4 indexed citations
20.
Santagostino, Elena, U. Martinowitz, Toshko Lissitchkov, et al.. (2016). Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial. Blood. 127(14). 1761–1769. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huub P J Willems Breakdown of academic impact, for papers by Angie Tuttle Breakdown of academic impact, for papers by M. Bhavnani Breakdown of academic impact, for papers by Tamara Everington Breakdown of academic impact, for papers by Elsy Sjörin Breakdown of academic impact, for papers by Piedad Villa Breakdown of academic impact, for papers by Livia Robbiolo Breakdown of academic impact, for papers by M.C. Trzeciak Breakdown of academic impact, for papers by Ariela Zivelin Breakdown of academic impact, for papers by Aurélie Rousseau
Rankless by CCL
2026